Vect-Horus designs and develops vectors that facilitate the targeting of therapeutic molecules or imaging agents to target organs, notably the brain and tumors. By combining these agents with vectors, developed to specifically target different receptors, Vect-Horus allows them to cross natural barriers (first and foremost, the blood-brain barrier) which slow down access to therapeutic molecules or agents. imagery to their target territory. The company has established proof of concept of its technology in animals by vectorizing different molecules.
Created in 2005, the company Vect-Horus is a spin-off from the Institute of Neurophysiopathology (INP, UMR7051, CNRS and Aix-Marseille University) directed by Dr. Michel Khrestchatisky, co-founder. To learn more about Vect-Horus, visit www.vect-horus.com.
VECT-HORUS S.A.S.
Address :
Faculty of Medicine La Timone 27 Boulevard Jean Moulin 1st floor Green wing13005 Marseille